StockNews.AISignal intelligencePublic signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Despite beating loss estimates, missed sales and a significant stock drop indicate bearish sentiment.
What happened, with direct paths to the underlying reporting
KPTI reported Q1 losses of $2.77 per share, beating estimates. Sales of $30.02 million missed the expected $35.24 million. Phase 3 SENTRY trial continues positively without modifications. FY2025 sales guidance remains at $140M-$155M, affirming market confidence. Analysts adjusted KPTI price targets post-earnings, varying significantly.
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.